By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS


Industry
Services

Segment
Publisher





Company News
Protein Sciences Corporation Release: Superior Protection By Flublok Influenza Vaccine In Seniors Documented In The New England Journal of Medicine 6/22/2017 9:15:27 AM
The New England Journal of Medicine Publishes Results From Aetion Real-World Data Analysis 6/21/2017 7:00:14 AM
Akcea Therapeutics Announces Publication In The New England Journal of Medicine Of Data With AKCEA-ANGPTL3-L Rx Showing Favorable Cardiometabolic Effects 5/25/2017 9:19:12 AM
Akcea Therapeutics Announces Publication In The New England Journal of Medicine Of Data With AKCEA-ANGPTL3-L Rx Showing Favorable Cardiometabolic Effects 5/25/2017 6:58:56 AM
Regeneron (REGN) Announces ANGPTL3/Evinacumab Publication In The New England Journal of Medicine And Positive Phase ll Data In People With HoFH 5/25/2017 6:53:51 AM
Pfizer (PFE) Release: Phase III OCTAVE Studies Of Oral Tofacitinib In Ulcerative Colitis Results Published In The New England Journal of Medicine 5/4/2017 6:48:42 AM
Hiding Data And Other Criticisms Of Big Pharma, The New England Journal of Medicine Reveals 4/24/2017 6:14:50 AM
NIH Study In The New England Journal of Medicine Shows Novartis Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia 4/20/2017 10:21:54 AM
NIH Study In The New England Journal of Medicine Shows Novartis AG (NVS) Drug Eltrombopag As First-Line Therapy With Standard Treatment Improves Responses In Severe Aplastic Anemia 4/20/2017 6:37:35 AM
The New England Journal of Medicine Publishes Pivotal Phase III Data For CSL Behring's Subcutaneous C1-Esterase Inhibitor In HAE Patients 3/23/2017 6:16:33 AM
12345678910...
//-->